IL271503A - Preparations and treatments for sleep disorders - Google Patents

Preparations and treatments for sleep disorders

Info

Publication number
IL271503A
IL271503A IL271503A IL27150319A IL271503A IL 271503 A IL271503 A IL 271503A IL 271503 A IL271503 A IL 271503A IL 27150319 A IL27150319 A IL 27150319A IL 271503 A IL271503 A IL 271503A
Authority
IL
Israel
Prior art keywords
treatments
sleep disorder
compositions
disorder compositions
sleep
Prior art date
Application number
IL271503A
Other languages
English (en)
Hebrew (he)
Inventor
Harry Karelis
Mara Gordon
Stewart Smith
Stewart Washer
Patrizia Washer
Original Assignee
Zelda Therapeutics Operations Pty Ltd
Harry Karelis
Mara Gordon
Stewart Smith
Stewart Washer
Patrizia Washer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2017902338A external-priority patent/AU2017902338A0/en
Application filed by Zelda Therapeutics Operations Pty Ltd, Harry Karelis, Mara Gordon, Stewart Smith, Stewart Washer, Patrizia Washer filed Critical Zelda Therapeutics Operations Pty Ltd
Publication of IL271503A publication Critical patent/IL271503A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Anesthesiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
IL271503A 2017-06-19 2019-12-17 Preparations and treatments for sleep disorders IL271503A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2017902338A AU2017902338A0 (en) 2017-06-19 Sleep Disorder Composition and Treatment Thereof
AU2017904818A AU2017904818A0 (en) 2017-11-29 Sleep Disorder Compositions and Treatments Thereof
PCT/AU2018/050604 WO2018232448A1 (en) 2017-06-19 2018-06-19 COMPOSITION AGAINST SLEEP APNEA AND RELATED TREATMENTS

Publications (1)

Publication Number Publication Date
IL271503A true IL271503A (en) 2020-02-27

Family

ID=62947713

Family Applications (1)

Application Number Title Priority Date Filing Date
IL271503A IL271503A (en) 2017-06-19 2019-12-17 Preparations and treatments for sleep disorders

Country Status (16)

Country Link
US (2) US20210145910A1 (cg-RX-API-DMAC7.html)
EP (1) EP3641754A4 (cg-RX-API-DMAC7.html)
JP (1) JP2020524151A (cg-RX-API-DMAC7.html)
KR (1) KR20200104278A (cg-RX-API-DMAC7.html)
CN (1) CN110944632A (cg-RX-API-DMAC7.html)
AU (2) AU2018100837B4 (cg-RX-API-DMAC7.html)
BR (1) BR112019026877A2 (cg-RX-API-DMAC7.html)
CA (1) CA3065563C (cg-RX-API-DMAC7.html)
CL (1) CL2019003635A1 (cg-RX-API-DMAC7.html)
CO (1) CO2019013887A2 (cg-RX-API-DMAC7.html)
IL (1) IL271503A (cg-RX-API-DMAC7.html)
MX (1) MX387442B (cg-RX-API-DMAC7.html)
NZ (1) NZ759963A (cg-RX-API-DMAC7.html)
PE (1) PE20201163A1 (cg-RX-API-DMAC7.html)
SG (1) SG11201912380XA (cg-RX-API-DMAC7.html)
WO (1) WO2018232448A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210013645A (ko) 2016-08-03 2021-02-04 젤다 테라퓨틱스 오퍼레이션즈 피티와이 엘티디 카나비스 조성물
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
EP3745884A1 (en) 2018-01-31 2020-12-09 Canopy Holdings, Llc Hemp powder
US11040932B2 (en) 2018-10-10 2021-06-22 Treehouse Biotech, Inc. Synthesis of cannabigerol
CA3027876A1 (en) * 2018-12-18 2020-06-18 Tetra Bio-Pharma Cannabis compositions and methods
NL2022616B1 (en) * 2019-02-21 2020-09-18 Patrick Alexander Unger Cannabigerol and pharmaceutical compositions comprising cannabigerol for use in the treatment of insomnia
US10946054B1 (en) * 2019-10-08 2021-03-16 Jenny's Rose, LLC Therapeutic cannabis extracts
US20220071946A1 (en) * 2020-03-03 2022-03-10 Alte Verde Llc Cannabis Treatment of Insomnia, Pain, and Skin Conditions
WO2021181248A1 (en) * 2020-03-09 2021-09-16 This Works Products Limited Compositions comprising functional fragrances and cannabis-derived compounds
CN112057894A (zh) * 2020-09-08 2020-12-11 云南工麻生物科技有限公司 一种提取大麻二酚的方法
EP4255404A4 (en) * 2020-12-04 2025-02-26 Cymra Life Sciences Limited ANTI-INFLAMMATORY COMPOSITIONS WITH CANNABIDIOL, DELTA-9-TETRAHYDROCANNABINOL AND LINALOOL
CN113143995A (zh) * 2021-01-21 2021-07-23 龙麻(上海)医药研发有限责任公司 一种大麻提取物舌下片及其制备工艺和应用
CN112999218A (zh) * 2021-01-21 2021-06-22 龙麻(上海)医药研发有限责任公司 一种具有镇静助眠功效的组合物及用途
EP4284349A1 (en) * 2021-01-28 2023-12-06 Zynerba Pharmaceuticals, Inc. Treatment of sleep apnea with cbd
CN112791151B (zh) * 2021-02-20 2022-04-01 山东新稀宝股份有限公司 一种具有改善睡眠功能的组合物及应用
DK181329B1 (en) 2021-05-04 2023-08-16 Cs Medica As Nasal sleep spray composition, method for its provision, and receptacle and kit comprising said composition
US20220401407A1 (en) * 2021-06-09 2022-12-22 Demetrix, Inc. Regulation of the sleep/wake cycle using cannabinoid compounds
EP4469039A4 (en) * 2022-01-27 2026-01-07 Defined Res Inc CANNABIDIOL (CBD) AND TERPENE FORMULATION TO IMPROVE RESTFUL SLEEP IN MEN

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6949582B1 (en) * 1999-05-27 2005-09-27 Wallace Walter H Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment
DE10051427C1 (de) * 2000-10-17 2002-06-13 Adam Mueller Verfahren zur Herstellung eines Tetrahydrocannabinol- und Cannabidiol-haltigen Extraktes aus Cannabis-Pflanzenmaterial sowie Cannabis-Extrakte
WO2004016277A2 (en) 2002-08-14 2004-02-26 Gw Pharma Limited Extraction of pharmaceutically active cannabinoids from plant materials
GB2418612A (en) 2004-10-01 2006-04-05 Gw Pharma Ltd Inhibition of tumour cell migration with cannabinoids
GB2478595B (en) 2010-03-12 2018-04-04 Gw Pharma Ltd Phytocannabinoids in the treatment of glioma
GB201117956D0 (en) 2011-10-18 2011-11-30 Otsuka Pharma Co Ltd Phytocannabinoids for use in the treatment of breast cancer
CN104619318A (zh) 2012-05-03 2015-05-13 回音制药公司 含有δ9-四氢大麻酚的大麻植物分离物及其制备方法
WO2014100231A1 (en) 2012-12-18 2014-06-26 Kotzker Consulting Llc Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity
US9763991B2 (en) * 2013-06-13 2017-09-19 Cannabis Science International Holding B.V. Composition for the treatment of neurobehavioral disorders
CN103355391A (zh) * 2013-08-13 2013-10-23 汕头大学医学院第一附属医院 一种五味健脑益智饼及其制备方法
US10265292B2 (en) 2013-09-18 2019-04-23 The Werc Shop, LLC Terpene-based compositions, processes methodologies
HRP20191097T1 (hr) 2013-10-29 2019-09-20 Biotech Institute, Llc Uzgoj, proizvodnja, obrada i upotreba specijalnog kanabisa
RU2016129536A (ru) 2013-10-31 2018-01-31 Фулл Спектрум Лабораториз, Лтд. Препараты на основе терпенов и каннабиноидов
CN105010577A (zh) 2014-04-17 2015-11-04 天津市麦地那食品贸易有限公司 一种火麻、橄榄、葡萄籽、葵花籽调和油
WO2015200049A1 (en) 2014-06-26 2015-12-30 Island Breeze Systems Ca, Llc Mdi related products and methods of use
US11793769B2 (en) 2014-08-25 2023-10-24 Jai Shankar Sukul Device with compositions for delivery to the lungs, the oral mucosa and the brain
BR112017008301B1 (pt) * 2014-10-21 2021-12-07 United Cannabis Corp Extratos de cannabis e métodos de sua preparação e uso
AU2015360349B2 (en) 2014-12-12 2020-10-08 Ojai Energetics Pbc Microencapsulated cannabinoid compositions
EP3250200A4 (en) * 2015-01-31 2018-09-19 Constance Therapeutics, Inc. Methods for preparation of cannabis oil extracts and compositions
US20160250270A1 (en) 2015-02-27 2016-09-01 Ebbu, LLC Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral
EP4193990A1 (en) * 2015-05-28 2023-06-14 Radius Pharmaceuticals, Inc. Stable cannabinoid formulations
IL246790A0 (en) * 2016-07-14 2016-09-29 Friedman Doron Self-dissolving compounds of cannabinoids
KR102447510B1 (ko) 2016-08-03 2022-09-27 젤리라 테라퓨틱스 오퍼레이션즈 피티와이 엘티디 카나비스 조성물
KR20210013645A (ko) * 2016-08-03 2021-02-04 젤다 테라퓨틱스 오퍼레이션즈 피티와이 엘티디 카나비스 조성물
US9649349B1 (en) * 2017-01-19 2017-05-16 Metamorphic Alchemy & Distillations, Inc. System and method for producing a terpene-enhanced cannibinoid concentrate
WO2018173049A1 (en) * 2017-03-20 2018-09-27 Kanabo Research Ltd. Vaporizable compositions comprising cannabinol
US20180352848A1 (en) * 2017-06-07 2018-12-13 NC3 Systems Smokable cannabis-based product with reduced psychoactive effects
US20200276155A1 (en) 2017-09-15 2020-09-03 Zelda Therapeutics Operations Pty Ltd Composition and method for treating autism
EP3745884A1 (en) * 2018-01-31 2020-12-09 Canopy Holdings, Llc Hemp powder
AU2018100924A4 (en) 2018-07-03 2018-08-09 Zelira Therapeutics Operations Pty Ltd Composition and method for treating pain
MX2022015799A (es) 2020-06-12 2023-04-11 Zelira Therapeutics Operations Pty Ltd Composicion y metodo para el tratamiento del dolor cronico.
MX2023005339A (es) 2020-11-06 2023-05-22 Zelira Therapeutics Operations Pty Ltd Tecnologia de encapsulacion de cannabinoides.

Also Published As

Publication number Publication date
AU2018100837A4 (en) 2018-07-26
US20230270808A1 (en) 2023-08-31
BR112019026877A2 (pt) 2020-06-30
EP3641754A4 (en) 2021-03-10
CL2019003635A1 (es) 2020-06-19
WO2018232448A1 (en) 2018-12-27
CA3065563C (en) 2023-06-13
CN110944632A (zh) 2020-03-31
EP3641754A1 (en) 2020-04-29
AU2018100837B4 (en) 2019-02-21
PE20201163A1 (es) 2020-10-28
MX2019015315A (es) 2020-02-17
AU2018286647B2 (en) 2024-03-28
CA3065563A1 (en) 2018-12-27
AU2018286647A1 (en) 2020-01-16
US12239680B2 (en) 2025-03-04
MX387442B (es) 2025-03-18
US20210145910A1 (en) 2021-05-20
CO2019013887A2 (es) 2020-04-01
SG11201912380XA (en) 2020-01-30
JP2020524151A (ja) 2020-08-13
NZ759963A (en) 2022-07-01
KR20200104278A (ko) 2020-09-03

Similar Documents

Publication Publication Date Title
IL271503A (en) Preparations and treatments for sleep disorders
IL301053B2 (en) Variants of hsd17b13 and their uses
ZA202002184B (en) Adenovirus and uses thereof
ZA202002191B (en) Adenovirus and uses thereof
ZA201907158B (en) Methods and compositions for treating sleep apnea
IL259570A (en) Combined therapy and their uses and methods
IL264813B (en) 2-oxo-imidazopyridines and their use
IL274220A (en) Adenovirus and its uses
IL269836B (en) Converted N-arylethyl-2-aminoquinoline-4-carboxamides and their use
IL265531A (en) N 3 -cyclically substituted thienouraciles and use thereof
IL264473A (en) GPR156 variants and their uses
IL275875A (en) Treatment and prevention of sleep disorders
SG11202002224XA (en) Composition and uses thereof
IL275211A (en) Fast and flexible segment chains - division
IL273671A (en) Cornoline variants and their use
GB201607910D0 (en) Microparticles and composition
ZA201902130B (en) Microparticle composition and use thereof
IL269843B (en) Converted N-arylethyl-2-arylquinoline-4-carboxamides and their use
GB201818517D0 (en) Nanoparticles and uses thereof
GB201703975D0 (en) Composition and methods
HK40029532A (en) Sleep disorder compositions and treatments thereof
IL271555A (en) Combining its uses and treatments
AU2017904818A0 (en) Sleep Disorder Compositions and Treatments Thereof
AU2017902338A0 (en) Sleep Disorder Composition and Treatment Thereof
GB201804409D0 (en) Compostions and uses thereof